Patents Assigned to DEUTSCHLAND KREBSFORSCHUNGSZENTRUM
  • Means and methods for treating and/or preventing natural AHR ligand-dependent cancer
    Patent number: 9593062
    Abstract: The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: March 14, 2017
    Assignee: DEUTSCHLAND KREBSFORSCHUNGSZENTRUM
    Inventors: Michael Platten, Christiane Opitz, Wolfgang Wick, Ulrike Litzenburger